GRAD7706
![](https://mb.cision.com/Public/20108/4022961/9ba388115dbaa6e5_800x800ar.jpg)
Photographer: Fotograf
Photographer: Fotograf
Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics in infectious disease medicine. Our product QuickMIC allows patients with sepsis to quickly receive specific guidance on the right antibiotic in the right dose. It saves lives, reduces healthcare costs and limits the spread of antibiotic resistance – one of the greatest global health threats of our time. Gradientech is headquartered in Uppsala. Visit www.gradientech.se for more information.
Investor Relations